Cargando…

Targeted cellular ablation based on the morphology of malignant cells

Treatment of glioblastoma multiforme (GBM) is especially challenging due to a shortage of methods to preferentially target diffuse infiltrative cells, and therapy-resistant glioma stem cell populations. Here we report a physical treatment method based on electrical disruption of cells, whose action...

Descripción completa

Detalles Bibliográficos
Autores principales: Ivey, Jill W., Latouche, Eduardo L., Sano, Michael B., Rossmeisl, John H., Davalos, Rafael V., Verbridge, Scott S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657158/
https://www.ncbi.nlm.nih.gov/pubmed/26596248
http://dx.doi.org/10.1038/srep17157
_version_ 1782402342756286464
author Ivey, Jill W.
Latouche, Eduardo L.
Sano, Michael B.
Rossmeisl, John H.
Davalos, Rafael V.
Verbridge, Scott S.
author_facet Ivey, Jill W.
Latouche, Eduardo L.
Sano, Michael B.
Rossmeisl, John H.
Davalos, Rafael V.
Verbridge, Scott S.
author_sort Ivey, Jill W.
collection PubMed
description Treatment of glioblastoma multiforme (GBM) is especially challenging due to a shortage of methods to preferentially target diffuse infiltrative cells, and therapy-resistant glioma stem cell populations. Here we report a physical treatment method based on electrical disruption of cells, whose action depends strongly on cellular morphology. Interestingly, numerical modeling suggests that while outer lipid bilayer disruption induced by long pulses (~100 μs) is enhanced for larger cells, short pulses (~1 μs) preferentially result in high fields within the cell interior, which scale in magnitude with nucleus size. Because enlarged nuclei represent a reliable indicator of malignancy, this suggested a means of preferentially targeting malignant cells. While we demonstrate killing of both normal and malignant cells using pulsed electric fields (PEFs) to treat spontaneous canine GBM, we proposed that properly tuned PEFs might provide targeted ablation based on nuclear size. Using 3D hydrogel models of normal and malignant brain tissues, which permit high-resolution interrogation during treatment testing, we confirmed that PEFs could be tuned to preferentially kill cancerous cells. Finally, we estimated the nuclear envelope electric potential disruption needed for cell death from PEFs. Our results may be useful in safely targeting the therapy-resistant cell niches that cause recurrence of GBM tumors.
format Online
Article
Text
id pubmed-4657158
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-46571582015-11-30 Targeted cellular ablation based on the morphology of malignant cells Ivey, Jill W. Latouche, Eduardo L. Sano, Michael B. Rossmeisl, John H. Davalos, Rafael V. Verbridge, Scott S. Sci Rep Article Treatment of glioblastoma multiforme (GBM) is especially challenging due to a shortage of methods to preferentially target diffuse infiltrative cells, and therapy-resistant glioma stem cell populations. Here we report a physical treatment method based on electrical disruption of cells, whose action depends strongly on cellular morphology. Interestingly, numerical modeling suggests that while outer lipid bilayer disruption induced by long pulses (~100 μs) is enhanced for larger cells, short pulses (~1 μs) preferentially result in high fields within the cell interior, which scale in magnitude with nucleus size. Because enlarged nuclei represent a reliable indicator of malignancy, this suggested a means of preferentially targeting malignant cells. While we demonstrate killing of both normal and malignant cells using pulsed electric fields (PEFs) to treat spontaneous canine GBM, we proposed that properly tuned PEFs might provide targeted ablation based on nuclear size. Using 3D hydrogel models of normal and malignant brain tissues, which permit high-resolution interrogation during treatment testing, we confirmed that PEFs could be tuned to preferentially kill cancerous cells. Finally, we estimated the nuclear envelope electric potential disruption needed for cell death from PEFs. Our results may be useful in safely targeting the therapy-resistant cell niches that cause recurrence of GBM tumors. Nature Publishing Group 2015-11-24 /pmc/articles/PMC4657158/ /pubmed/26596248 http://dx.doi.org/10.1038/srep17157 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Ivey, Jill W.
Latouche, Eduardo L.
Sano, Michael B.
Rossmeisl, John H.
Davalos, Rafael V.
Verbridge, Scott S.
Targeted cellular ablation based on the morphology of malignant cells
title Targeted cellular ablation based on the morphology of malignant cells
title_full Targeted cellular ablation based on the morphology of malignant cells
title_fullStr Targeted cellular ablation based on the morphology of malignant cells
title_full_unstemmed Targeted cellular ablation based on the morphology of malignant cells
title_short Targeted cellular ablation based on the morphology of malignant cells
title_sort targeted cellular ablation based on the morphology of malignant cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4657158/
https://www.ncbi.nlm.nih.gov/pubmed/26596248
http://dx.doi.org/10.1038/srep17157
work_keys_str_mv AT iveyjillw targetedcellularablationbasedonthemorphologyofmalignantcells
AT latoucheeduardol targetedcellularablationbasedonthemorphologyofmalignantcells
AT sanomichaelb targetedcellularablationbasedonthemorphologyofmalignantcells
AT rossmeisljohnh targetedcellularablationbasedonthemorphologyofmalignantcells
AT davalosrafaelv targetedcellularablationbasedonthemorphologyofmalignantcells
AT verbridgescotts targetedcellularablationbasedonthemorphologyofmalignantcells